"Cellular Reprogramming" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
A process where fully differentiated or specialized cells revert to pluripotency or a less differentiated cell type.
| Descriptor ID |
D065150
|
| MeSH Number(s) |
G04.152.262 G05.135
|
| Concept/Terms |
|
Below are MeSH descriptors whose meaning is more general than "Cellular Reprogramming".
Below are MeSH descriptors whose meaning is more specific than "Cellular Reprogramming".
This graph shows the total number of publications written about "Cellular Reprogramming" by people in this website by year, and whether "Cellular Reprogramming" was a major or minor topic of these publications.
To see the data from this visualization as text,
click here.
| Year | Major Topic | Minor Topic | Total |
|---|
| 2014 | 1 | 1 | 2 |
| 2015 | 1 | 0 | 1 |
| 2016 | 0 | 2 | 2 |
| 2017 | 2 | 0 | 2 |
| 2020 | 1 | 0 | 1 |
To return to the timeline,
click here.
Below are the most recent publications written about "Cellular Reprogramming" by people in Profiles.
-
Monocyte metabolic reprogramming promotes pro-inflammatory activity and Staphylococcus aureus biofilm clearance. PLoS Pathog. 2020 03; 16(3):e1008354.
-
MUC1 facilitates metabolomic reprogramming in triple-negative breast cancer. PLoS One. 2017; 12(5):e0176820.
-
CD147: a small molecule transporter ancillary protein at the crossroad of multiple hallmarks of cancer and metabolic reprogramming. Oncotarget. 2017 Jan 24; 8(4):6742-6762.
-
Regulation of the DNA Methylation Landscape in Human Somatic Cell Reprogramming by the miR-29 Family. Stem Cell Reports. 2016 07 12; 7(1):43-54.
-
Histiocytic sarcoma as a secondary malignancy: pathobiology, diagnosis, and treatment. Eur J Haematol. 2016 Jul; 97(1):9-16.
-
Identification of the specific epigenetic alterations associated with chemo-resistance via reprogramming of cancer cells. Med Hypotheses. 2015 Dec; 85(6):710-4.
-
Role of PUF-8/PUF protein in stem cell control, sperm-oocyte decision and cell fate reprogramming. J Cell Physiol. 2014 Oct; 229(10):1306-11.
-
Bright/Arid3A acts as a barrier to somatic cell reprogramming through direct regulation of Oct4, Sox2, and Nanog. Stem Cell Reports. 2014 Jan 14; 2(1):26-35.